PATH Disposable Syringe Jet Injector (DSJI)

PATH

The PATH [disposable-syringe jet injector (DSJI)](http://sites.path.org/vpdt/needle-free-inn/dsji/ “http://sites.path.org/vpdt/needle-free-inn/dsji/”) is a sterile needle-free device that uses a single-dose syringe and a pressurized liquid stream rather than a needle to penetrate through the skin and deliver injections to the intradermal, subcutaneous, or intramuscular tissues. The PATH DSJI aims to reduce needle reuse and the associated disease spread due to shortages of sterile needles and trained lab workers. An estimated 23.5 million new HIV, hepatitis B, and hepatitis C infections occur every year through needle reuse and accidental needle stick injuries.

Product description

The PATH [disposable-syringe jet injector (DSJI)](http://sites.path.org/vpdt/needle-free-inn/dsji/ “http://sites.path.org/vpdt/needle-free-inn/dsji/”) is a sterile needle-free device that uses a single-dose syringe and a pressurized liquid stream rather than a needle to penetrate through the skin and deliver injections to the intradermal, subcutaneous, or intramuscular tissues. The PATH DSJI aims to reduce needle reuse and the associated disease spread due to shortages of sterile needles and trained lab workers. An estimated 23.5 million new HIV, hepatitis B, and hepatitis C infections occur every year through needle reuse and accidental needle stick injuries.

Target region(s)
Brazil, China, Cuba, India, South Africa
Distributors/implementing organizations

PATH [partners with privately-held manufacturers such as PharmaJet](http://www.path.org/publications/files/OTP_health_tech_within_reach.pdf “http://www.path.org/publications/files/OTP_health_tech_within_reach.pdf”) that sell the product to medical dispensaries. PATH is collaborating with partners to assess the appropriateness of DSJIs for developing-country use. Research and evaluation of the device includes studies to test that it is as effective as needle-based injections.

Market suggested retail price

Unknown, as this product is not available on the market yet.

Competitive landscape

[PharmaJet Needleless Injection Device](http://pharmajet.com/product/ “http://pharmajet.com/product/”), Biojector, Vitajet 3, Serojet, and many more.

SDG targeted

Goal [3] (http://www.un.org/sustainabledevelopment/sustainable-development-goals/ “http://www.un.org/sustainabledevelopment/sustainable-development-goals/”): to improve and promote good health.

 

Target user(s)

[Health care professionals](http://sites.path.org/vpdt/needle-free-inn/dsji/ “http://sites.path.org/vpdt/needle-free-inn/dsji/”) in low resource settings administering vaccines or essential medicines

The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects https://t.co/MlRH1H0x2F